AngioDynamics Reports Fiscal 2018 Fourth Quarter and Full-Year Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
AngioDynamics (ANGO) Misses Q4 EPS by 1c, Revenues Miss
July 11, 2018 7:02 AM EDTAngioDynamics (NASDAQ: ANGO) reported Q4 EPS of $0.20, $0.01 worse than the analyst estimate of $0.21. Revenue for the quarter came in at $88.3 million versus the consensus estimate of $89.32 million.
Fiscal 2018 Fourth Quarter Highlights
Net sales of $88.3 million, an increase of 1.6% year over yearGross margin expanded 500 basis points year over year to 53.7%GAAP EPS... More